Evidence map›Paper›PMID 37025159›Full record

ArticleVirus evolution2023

Purifying selection decreases the potential for Bangui orthobunyavirus outbreaks in humans.

Gregory S Orf, Lester J Perez, Todd V Meyer, Ka-Cheung Luk, Kenn Forberg, Mary A Rodgers, Abbas Hadji, Linda James, Samuel Mampunza, Asmeeta Achari and 6 more

Open access · goldAbstract read
In one paragraph

Article in Virus evolution, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Assessing Nanopore Targeted Sequencing for the Diagnosis of Pulmonary Infections: A Comparative Multidisease Approach.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  5. Article
  6. Fort Sherman Virus Infection in Human, Peru, 2020.Emerging infectious diseases · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Gregory S OrfAbbott Laboratories and Abbott Pandemic Defense Coalition, Abbott Park, IL 60064, USA.ORCID https://orcid.org/0000-0002-4853-8518
Lester J PerezAbbott Laboratories and Abbott Pandemic Defense Coalition, Abbott Park, IL 60064, USA.ORCID https://orcid.org/0000-0002-5717-5181
Todd V MeyerAbbott Laboratories and Abbott Pandemic Defense Coalition, Abbott Park, IL 60064, USA.
Ka-Cheung LukAbbott Laboratories and Abbott Pandemic Defense Coalition, Abbott Park, IL 60064, USA.
Kenn ForbergAbbott Laboratories and Abbott Pandemic Defense Coalition, Abbott Park, IL 60064, USA.
Mary A RodgersAbbott Laboratories and Abbott Pandemic Defense Coalition, Abbott Park, IL 60064, USA.
Abbas HadjiAbbott Laboratories and Abbott Pandemic Defense Coalition, Abbott Park, IL 60064, USA.
Linda JamesUniversité Protestante au Congo, Kinshasa, Democratic Republic of the Congo.
Samuel MampunzaUniversité Protestante au Congo, Kinshasa, Democratic Republic of the Congo.
Asmeeta AchariDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Guixia YuDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Scot FedermanDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94143, USA.ORCID https://orcid.org/0000-0001-8712-3131
Charles Y ChiuDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Carole A McArthurUniversity of Missouri-Kansas City, Kansas City, MO 64110, USA.
Gavin A ClohertyAbbott Laboratories and Abbott Pandemic Defense Coalition, Abbott Park, IL 60064, USA.
Michael G BergAbbott Laboratories and Abbott Pandemic Defense Coalition, Abbott Park, IL 60064, USA.ORCID https://orcid.org/0000-0003-0233-5819
Abbott Fund · USUniversity of California, San Francisco · USUniversité Protestante au Congo · CDUniversity of Missouri–Kansas City · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogens carried by insects, such as bunyaviruses, are frequently transmitted into human populations and cause diseases. Knowing which spillover events represent a public health threat remains a challenge. Metagenomic next-generation sequencing (mNGS) can support infectious disease diagnostics by enabling the detection of any pathogen from clinical specimens. mNGS was performed on blood samples to identify potential viral coinfections in human immunodeficiency virus (HIV)-positive individuals from Kinshasa, the Democratic Republic of the Congo (DRC), participating in an HIV diversity cohort study. Time-resolved phylogenetics and molecular assay development assisted in viral characterization. The nearly complete genome of a novel orthobunyavirus related to Nyangole virus, a virus previously identified in neighboring Uganda, was assembled from a hepatitis B virus-positive patient. A quantitative polymerase chain reaction assay was designed and used to screen >2,500 plasma samples from Cameroon, the DRC, and Uganda, failing to identify any additional cases. The recent sequencing of a US Center for Disease Control Arbovirus Reference Collection revealed that this same virus, now named Bangui virus, was first isolated in 1970 from an individual in the Central African Republic. Time-scaled phylogenetic analyses of Bangui with the related Anopheles and Tanga serogroup complexes indicate that this virus emerged nearly 10,000 years ago. Pervasive and episodic models further suggest that this virus is under purifying selection and that only distant common ancestors were subject to positive selection events. This study represents only the second identification of a Bangui virus infection in over 50 years. The presumed rarity of Bangui virus infections in humans can be explained by its constraint to an avian host and insect vector, precluding efficient transmission into the human population. Our results demonstrate that molecular phylogenetic analyses can provide insights into the threat posed by novel or re-emergent viruses identified by mNGS.

Indexed as

Bangui virusbunyavirusfebrile illnessthe Democratic Republic of the Congovirus discovery

Identifiers

PMID37025159
PMCPMC10072187
OpenAlexW4323538149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.